The FDA has officially approved RHA Dynamic Volume for adult patients seeking cheek enhancement and correction of age-related midface volume loss. This new indication expands treatment options for aesthetic practices, offering a filler designed to provide natural-looking results while supporting dynamic facial movement.
What RHA Dynamic Volume Offers
RHA Dynamic Volume, previously known as RHA 4 Mepi, is a hyaluronic acid-based dermal filler developed by Teoxane and Revance. Engineered with Preserved Network Technology (PNT), the product maintains the natural structure of hyaluronic acid while delivering long-lasting volume. This technology allows for high elasticity and flexibility, ensuring that expressions remain natural while contours are enhanced.
The updated approval highlights the filler’s versatility in midface volumization, making it a valuable option for practitioners seeking both aesthetic precision and patient satisfaction.
Clinical Evidence Supporting FDA Approval
The FDA’s approval was backed by a 52-week Phase III clinical trial comparing RHA Dynamic Volume to Juvéderm Voluma XC in patients with moderate to severe midface volume loss. Key findings from the study include:
- Comparable effectiveness to Voluma XC for cheek and midface augmentation
- Fewer treatment sessions and touch-ups required to achieve optimal outcomes
- Over 94% of patients reported natural-looking and natural-feeling results both at rest and during facial movement for up to one year
- No late-onset or serious treatment-related adverse events, and no granulomas or delayed inflammatory responses reported
These results demonstrate that RHA Dynamic Volume not only restores midface volume but also preserves natural facial expressions, addressing one of the most common patient concerns with traditional fillers.
Benefits for Practices and Patients
With the new FDA-approved indication, aesthetic clinics can offer:
- Officially approved midface and cheek augmentation treatments
- A versatile tool to complement other fillers in facial contouring
- Predictable, long-lasting results that enhance patient satisfaction
RHA Dynamic Volume adds a modern, dynamic approach to midface rejuvenation, supporting both aesthetic precision and natural movement.
How OptiMantra Supports Safe and Compliant Filler Practice
Managing injectable treatments like RHA Dynamic Volume requires careful documentation, patient tracking, and compliance with medical regulations. OptiMantra is an EMR and practice management system that simplifies these workflows by helping clinics:
- Record detailed injection sites, volumes, and product lot numbers
- Track patient outcomes and treatment history longitudinally
- Maintain audit-ready documentation for regulatory compliance
- Integrate treatment protocols into the patient record
By centralizing documentation and automating record-keeping, OptiMantra ensures your practice delivers innovative aesthetic treatments safely, efficiently, and confidently. Try a free trial or schedule a live demo today!
Legal Disclaimer: This article is provided for informational purposes only and does not constitute medical advice, clinical guidance, or regulatory recommendations. Practitioners must follow FDA-approved indications, product labeling, and all applicable local and federal regulations when administering dermal fillers. Clinics should consult official product instructions, professional societies, and CME-accredited training before offering treatments.
Source:
Moeller, M. (2026, January 15th). FDA Approves RHA Dynamic Volume for Cheek Augmentation, Midface Contouring. American Med Spa Association. https://americanmedspa.org/news/fda-approves-rha-dynamic-volume-for-cheek-augmentation-midface-contouring
